X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ALKEM LABORATORIES SHASUN PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 123.9 - - View Chart
P/BV x 8.5 6.2 138.3% View Chart
Dividend Yield % 0.2 0.7 33.2%  

Financials

 SHASUN PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ALKEM LABORATORIES
Mar-16
SHASUN PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs941,589 5.9%   
Low Rs461,232 3.7%   
Sales per share (Unadj.) Rs214.2417.5 51.3%  
Earnings per share (Unadj.) Rs5.356.3 9.5%  
Cash flow per share (Unadj.) Rs15.864.7 24.4%  
Dividends per share (Unadj.) Rs1.0012.70 7.9%  
Dividend yield (eoy) %1.40.9 158.9%  
Book value per share (Unadj.) Rs53.3292.9 18.2%  
Shares outstanding (eoy) m56.62119.57 47.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 9.7%   
Avg P/E ratio x13.125.1 52.3%  
P/CF ratio (eoy) x4.421.8 20.3%  
Price / Book Value ratio x1.34.8 27.2%  
Dividend payout %18.722.6 83.1%   
Avg Mkt Cap Rs m3,958168,653 2.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1649,171 23.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,12749,915 24.3%  
Other income Rs m2291,645 13.9%   
Total revenues Rs m12,35651,561 24.0%   
Gross profit Rs m1,0098,482 11.9%  
Depreciation Rs m5941,006 59.0%   
Interest Rs m415671 61.9%   
Profit before tax Rs m2308,451 2.7%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,606 -4.5%   
Profit after tax Rs m3026,731 4.5%  
Gross profit margin %8.317.0 49.0%  
Effective tax rate %-31.719.0 -166.6%   
Net profit margin %2.513.5 18.5%  
BALANCE SHEET DATA
Current assets Rs m6,88427,062 25.4%   
Current liabilities Rs m8,45615,324 55.2%   
Net working cap to sales %-13.023.5 -55.1%  
Current ratio x0.81.8 46.1%  
Inventory Days Days6267 92.7%  
Debtors Days Days10841 260.5%  
Net fixed assets Rs m4,97012,610 39.4%   
Share capital Rs m113239 47.4%   
"Free" reserves Rs m2,87534,490 8.3%   
Net worth Rs m3,02035,027 8.6%   
Long term debt Rs m1,8171,212 150.0%   
Total assets Rs m13,34754,387 24.5%  
Interest coverage x1.613.6 11.4%   
Debt to equity ratio x0.60 1,739.6%  
Sales to assets ratio x0.90.9 99.0%   
Return on assets %5.413.6 39.5%  
Return on equity %10.019.2 52.1%  
Return on capital %13.324.9 53.6%  
Exports to sales %46.412.9 358.1%   
Imports to sales %14.23.1 461.7%   
Exports (fob) Rs m5,6226,461 87.0%   
Imports (cif) Rs m1,7281,540 112.2%   
Fx inflow Rs m5,8436,563 89.0%   
Fx outflow Rs m2,1733,012 72.2%   
Net fx Rs m3,6693,552 103.3%   
CASH FLOW
From Operations Rs m3987,259 5.5%  
From Investments Rs m-1,6351,864 -87.7%  
From Financial Activity Rs m1,309-9,273 -14.1%  
Net Cashflow Rs m71-150 -47.5%  

Share Holding

Indian Promoters % 39.2 66.9 58.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 33.1 10.9%  
FIIs % 17.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 0.0 -  
Shareholders   20,750 68,381 30.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES SHASUN LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - ORCHID PHARMA LTD COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS